[{"Assets_0_Q3_USD":334077000.0,"CommonStockSharesOutstanding_0_Q3_shares":310180645.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-106618000.0,"NetIncomeLoss_1_Q3_USD":-44607000.0,"NetIncomeLoss_3_Q3_USD":-132927000.0,"StockholdersEquity_0_Q3_USD":-74151000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]